# Spruce Biosciences, Inc.: Form SCHEDULE 13D/A, filed Feb 18, 2026

- Company: [Spruce Biosciences, Inc.](/companies/sprb.md) (CIK 1683553)
- Form: SCHEDULE 13D/A
- Filed: 2026-02-18
- Accepted by EDGAR: Feb 18, 2026, 17:27 ET
- Period: not reported
- Accession: 0001493152-26-007364
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1683553/000149315226007364/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1683553/000149315226007364/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1683553/000149315226007364/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 18, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-007364. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.